Tanaka, Y.; Onozato, M.; Mikami, T.; Kohwi-Shigematsu, T.; Fukushima, T.; Kondo, M.
Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren’s Syndrome in SATB1-Conditional Knockout Mice. Int. J. Mol. Sci. 2021, 22, 10125.
https://doi.org/10.3390/ijms221810125
AMA Style
Tanaka Y, Onozato M, Mikami T, Kohwi-Shigematsu T, Fukushima T, Kondo M.
Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren’s Syndrome in SATB1-Conditional Knockout Mice. International Journal of Molecular Sciences. 2021; 22(18):10125.
https://doi.org/10.3390/ijms221810125
Chicago/Turabian Style
Tanaka, Yuriko, Mayu Onozato, Tetuo Mikami, Terumi Kohwi-Shigematsu, Takeshi Fukushima, and Motonari Kondo.
2021. "Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren’s Syndrome in SATB1-Conditional Knockout Mice" International Journal of Molecular Sciences 22, no. 18: 10125.
https://doi.org/10.3390/ijms221810125
APA Style
Tanaka, Y., Onozato, M., Mikami, T., Kohwi-Shigematsu, T., Fukushima, T., & Kondo, M.
(2021). Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren’s Syndrome in SATB1-Conditional Knockout Mice. International Journal of Molecular Sciences, 22(18), 10125.
https://doi.org/10.3390/ijms221810125
